The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Immuno-Oncology Market Research Report 2025
Synopsis
Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body's own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.
The global Immuno-Oncology market was valued at US$ 43650 million in 2023 and is anticipated to reach US$ 116680 million by 2030, witnessing a CAGR of 14.9% during the forecast period 2024-2030.
The industry's leading producers are Bristol-Myers Squibb, Merck & Co and Roche AG, with revenues of 27.89%, 22.10% and 20.85%, respectively, in 2019.
This report aims to provide a comprehensive presentation of the global market for Immuno-Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immuno-Oncology.
Report Scope
The Immuno-Oncology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immuno-Oncology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immuno-Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol-Myers Squibb
Merck & Co., Inc.
Roche AG
AstraZeneca, Plc
Sanofi S.A.
Dendreon Pharmaceuticals
Novartis
Gilead Sciences Inc.
Merck KGaA
Segment by Type
Immune Checkpoint Inhibitors
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Others
Segment by Application
Hospitals
Drugstores
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immuno-Oncology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body's own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.
The global Immuno-Oncology market was valued at US$ 43650 million in 2023 and is anticipated to reach US$ 116680 million by 2030, witnessing a CAGR of 14.9% during the forecast period 2024-2030.
The industry's leading producers are Bristol-Myers Squibb, Merck & Co and Roche AG, with revenues of 27.89%, 22.10% and 20.85%, respectively, in 2019.
This report aims to provide a comprehensive presentation of the global market for Immuno-Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immuno-Oncology.
Report Scope
The Immuno-Oncology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immuno-Oncology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immuno-Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol-Myers Squibb
Merck & Co., Inc.
Roche AG
AstraZeneca, Plc
Sanofi S.A.
Dendreon Pharmaceuticals
Novartis
Gilead Sciences Inc.
Merck KGaA
Segment by Type
Immune Checkpoint Inhibitors
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Others
Segment by Application
Hospitals
Drugstores
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immuno-Oncology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno-Oncology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immune Checkpoint Inhibitors
1.2.3 Cytokine-Based Immunotherapy
1.2.4 Cancer Vaccines
1.2.5 CAR-T Cell Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Immuno-Oncology Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immuno-Oncology Market Perspective (2019-2030)
2.2 Immuno-Oncology Growth Trends by Region
2.2.1 Global Immuno-Oncology Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Immuno-Oncology Historic Market Size by Region (2019-2024)
2.2.3 Immuno-Oncology Forecasted Market Size by Region (2025-2030)
2.3 Immuno-Oncology Market Dynamics
2.3.1 Immuno-Oncology Industry Trends
2.3.2 Immuno-Oncology Market Drivers
2.3.3 Immuno-Oncology Market Challenges
2.3.4 Immuno-Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immuno-Oncology Players by Revenue
3.1.1 Global Top Immuno-Oncology Players by Revenue (2019-2024)
3.1.2 Global Immuno-Oncology Revenue Market Share by Players (2019-2024)
3.2 Global Immuno-Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immuno-Oncology Revenue
3.4 Global Immuno-Oncology Market Concentration Ratio
3.4.1 Global Immuno-Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno-Oncology Revenue in 2023
3.5 Immuno-Oncology Key Players Head office and Area Served
3.6 Key Players Immuno-Oncology Product Solution and Service
3.7 Date of Enter into Immuno-Oncology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immuno-Oncology Breakdown Data by Type
4.1 Global Immuno-Oncology Historic Market Size by Type (2019-2024)
4.2 Global Immuno-Oncology Forecasted Market Size by Type (2025-2030)
5 Immuno-Oncology Breakdown Data by Application
5.1 Global Immuno-Oncology Historic Market Size by Application (2019-2024)
5.2 Global Immuno-Oncology Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Immuno-Oncology Market Size (2019-2030)
6.2 North America Immuno-Oncology Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Immuno-Oncology Market Size by Country (2019-2024)
6.4 North America Immuno-Oncology Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immuno-Oncology Market Size (2019-2030)
7.2 Europe Immuno-Oncology Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Immuno-Oncology Market Size by Country (2019-2024)
7.4 Europe Immuno-Oncology Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immuno-Oncology Market Size (2019-2030)
8.2 Asia-Pacific Immuno-Oncology Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Immuno-Oncology Market Size by Region (2019-2024)
8.4 Asia-Pacific Immuno-Oncology Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immuno-Oncology Market Size (2019-2030)
9.2 Latin America Immuno-Oncology Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Immuno-Oncology Market Size by Country (2019-2024)
9.4 Latin America Immuno-Oncology Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immuno-Oncology Market Size (2019-2030)
10.2 Middle East & Africa Immuno-Oncology Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Immuno-Oncology Market Size by Country (2019-2024)
10.4 Middle East & Africa Immuno-Oncology Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Detail
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Immuno-Oncology Introduction
11.1.4 Bristol-Myers Squibb Revenue in Immuno-Oncology Business (2019-2024)
11.1.5 Bristol-Myers Squibb Recent Development
11.2 Merck & Co., Inc.
11.2.1 Merck & Co., Inc. Company Detail
11.2.2 Merck & Co., Inc. Business Overview
11.2.3 Merck & Co., Inc. Immuno-Oncology Introduction
11.2.4 Merck & Co., Inc. Revenue in Immuno-Oncology Business (2019-2024)
11.2.5 Merck & Co., Inc. Recent Development
11.3 Roche AG
11.3.1 Roche AG Company Detail
11.3.2 Roche AG Business Overview
11.3.3 Roche AG Immuno-Oncology Introduction
11.3.4 Roche AG Revenue in Immuno-Oncology Business (2019-2024)
11.3.5 Roche AG Recent Development
11.4 AstraZeneca, Plc
11.4.1 AstraZeneca, Plc Company Detail
11.4.2 AstraZeneca, Plc Business Overview
11.4.3 AstraZeneca, Plc Immuno-Oncology Introduction
11.4.4 AstraZeneca, Plc Revenue in Immuno-Oncology Business (2019-2024)
11.4.5 AstraZeneca, Plc Recent Development
11.5 Sanofi S.A.
11.5.1 Sanofi S.A. Company Detail
11.5.2 Sanofi S.A. Business Overview
11.5.3 Sanofi S.A. Immuno-Oncology Introduction
11.5.4 Sanofi S.A. Revenue in Immuno-Oncology Business (2019-2024)
11.5.5 Sanofi S.A. Recent Development
11.6 Dendreon Pharmaceuticals
11.6.1 Dendreon Pharmaceuticals Company Detail
11.6.2 Dendreon Pharmaceuticals Business Overview
11.6.3 Dendreon Pharmaceuticals Immuno-Oncology Introduction
11.6.4 Dendreon Pharmaceuticals Revenue in Immuno-Oncology Business (2019-2024)
11.6.5 Dendreon Pharmaceuticals Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Immuno-Oncology Introduction
11.7.4 Novartis Revenue in Immuno-Oncology Business (2019-2024)
11.7.5 Novartis Recent Development
11.8 Gilead Sciences Inc.
11.8.1 Gilead Sciences Inc. Company Detail
11.8.2 Gilead Sciences Inc. Business Overview
11.8.3 Gilead Sciences Inc. Immuno-Oncology Introduction
11.8.4 Gilead Sciences Inc. Revenue in Immuno-Oncology Business (2019-2024)
11.8.5 Gilead Sciences Inc. Recent Development
11.9 Merck KGaA
11.9.1 Merck KGaA Company Detail
11.9.2 Merck KGaA Business Overview
11.9.3 Merck KGaA Immuno-Oncology Introduction
11.9.4 Merck KGaA Revenue in Immuno-Oncology Business (2019-2024)
11.9.5 Merck KGaA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Immuno-Oncology Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Immune Checkpoint Inhibitors
Table 3. Key Players of Cytokine-Based Immunotherapy
Table 4. Key Players of Cancer Vaccines
Table 5. Key Players of CAR-T Cell Therapy
Table 6. Key Players of Others
Table 7. Global Immuno-Oncology Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Immuno-Oncology Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Immuno-Oncology Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Immuno-Oncology Market Share by Region (2019-2024)
Table 11. Global Immuno-Oncology Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Immuno-Oncology Market Share by Region (2025-2030)
Table 13. Immuno-Oncology Market Trends
Table 14. Immuno-Oncology Market Drivers
Table 15. Immuno-Oncology Market Challenges
Table 16. Immuno-Oncology Market Restraints
Table 17. Global Immuno-Oncology Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Immuno-Oncology Market Share by Players (2019-2024)
Table 19. Global Top Immuno-Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology as of 2023)
Table 20. Ranking of Global Top Immuno-Oncology Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Immuno-Oncology Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Immuno-Oncology Product Solution and Service
Table 24. Date of Enter into Immuno-Oncology Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Immuno-Oncology Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Immuno-Oncology Revenue Market Share by Type (2019-2024)
Table 28. Global Immuno-Oncology Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Immuno-Oncology Revenue Market Share by Type (2025-2030)
Table 30. Global Immuno-Oncology Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Immuno-Oncology Revenue Market Share by Application (2019-2024)
Table 32. Global Immuno-Oncology Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Immuno-Oncology Revenue Market Share by Application (2025-2030)
Table 34. North America Immuno-Oncology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Immuno-Oncology Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Immuno-Oncology Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Immuno-Oncology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Immuno-Oncology Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Immuno-Oncology Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Immuno-Oncology Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Immuno-Oncology Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Immuno-Oncology Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Immuno-Oncology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Immuno-Oncology Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Immuno-Oncology Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Immuno-Oncology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Immuno-Oncology Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Immuno-Oncology Market Size by Country (2025-2030) & (US$ Million)
Table 49. Bristol-Myers Squibb Company Detail
Table 50. Bristol-Myers Squibb Business Overview
Table 51. Bristol-Myers Squibb Immuno-Oncology Product
Table 52. Bristol-Myers Squibb Revenue in Immuno-Oncology Business (2019-2024) & (US$ Million)
Table 53. Bristol-Myers Squibb Recent Development
Table 54. Merck & Co., Inc. Company Detail
Table 55. Merck & Co., Inc. Business Overview
Table 56. Merck & Co., Inc. Immuno-Oncology Product
Table 57. Merck & Co., Inc. Revenue in Immuno-Oncology Business (2019-2024) & (US$ Million)
Table 58. Merck & Co., Inc. Recent Development
Table 59. Roche AG Company Detail
Table 60. Roche AG Business Overview
Table 61. Roche AG Immuno-Oncology Product
Table 62. Roche AG Revenue in Immuno-Oncology Business (2019-2024) & (US$ Million)
Table 63. Roche AG Recent Development
Table 64. AstraZeneca, Plc Company Detail
Table 65. AstraZeneca, Plc Business Overview
Table 66. AstraZeneca, Plc Immuno-Oncology Product
Table 67. AstraZeneca, Plc Revenue in Immuno-Oncology Business (2019-2024) & (US$ Million)
Table 68. AstraZeneca, Plc Recent Development
Table 69. Sanofi S.A. Company Detail
Table 70. Sanofi S.A. Business Overview
Table 71. Sanofi S.A. Immuno-Oncology Product
Table 72. Sanofi S.A. Revenue in Immuno-Oncology Business (2019-2024) & (US$ Million)
Table 73. Sanofi S.A. Recent Development
Table 74. Dendreon Pharmaceuticals Company Detail
Table 75. Dendreon Pharmaceuticals Business Overview
Table 76. Dendreon Pharmaceuticals Immuno-Oncology Product
Table 77. Dendreon Pharmaceuticals Revenue in Immuno-Oncology Business (2019-2024) & (US$ Million)
Table 78. Dendreon Pharmaceuticals Recent Development
Table 79. Novartis Company Detail
Table 80. Novartis Business Overview
Table 81. Novartis Immuno-Oncology Product
Table 82. Novartis Revenue in Immuno-Oncology Business (2019-2024) & (US$ Million)
Table 83. Novartis Recent Development
Table 84. Gilead Sciences Inc. Company Detail
Table 85. Gilead Sciences Inc. Business Overview
Table 86. Gilead Sciences Inc. Immuno-Oncology Product
Table 87. Gilead Sciences Inc. Revenue in Immuno-Oncology Business (2019-2024) & (US$ Million)
Table 88. Gilead Sciences Inc. Recent Development
Table 89. Merck KGaA Company Detail
Table 90. Merck KGaA Business Overview
Table 91. Merck KGaA Immuno-Oncology Product
Table 92. Merck KGaA Revenue in Immuno-Oncology Business (2019-2024) & (US$ Million)
Table 93. Merck KGaA Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immuno-Oncology Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Immuno-Oncology Market Share by Type: 2023 VS 2030
Figure 3. Immune Checkpoint Inhibitors Features
Figure 4. Cytokine-Based Immunotherapy Features
Figure 5. Cancer Vaccines Features
Figure 6. CAR-T Cell Therapy Features
Figure 7. Others Features
Figure 8. Global Immuno-Oncology Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Immuno-Oncology Market Share by Application: 2023 VS 2030
Figure 10. Hospitals Case Studies
Figure 11. Drugstores Case Studies
Figure 12. Others Case Studies
Figure 13. Immuno-Oncology Report Years Considered
Figure 14. Global Immuno-Oncology Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Immuno-Oncology Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Immuno-Oncology Market Share by Region: 2023 VS 2030
Figure 17. Global Immuno-Oncology Market Share by Players in 2023
Figure 18. Global Top Immuno-Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Immuno-Oncology Revenue in 2023
Figure 20. North America Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Immuno-Oncology Market Share by Country (2019-2030)
Figure 22. United States Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Immuno-Oncology Market Share by Country (2019-2030)
Figure 26. Germany Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Immuno-Oncology Market Share by Region (2019-2030)
Figure 34. China Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Immuno-Oncology Market Share by Country (2019-2030)
Figure 42. Mexico Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Immuno-Oncology Market Share by Country (2019-2030)
Figure 46. Turkey Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Immuno-Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Bristol-Myers Squibb Revenue Growth Rate in Immuno-Oncology Business (2019-2024)
Figure 49. Merck & Co., Inc. Revenue Growth Rate in Immuno-Oncology Business (2019-2024)
Figure 50. Roche AG Revenue Growth Rate in Immuno-Oncology Business (2019-2024)
Figure 51. AstraZeneca, Plc Revenue Growth Rate in Immuno-Oncology Business (2019-2024)
Figure 52. Sanofi S.A. Revenue Growth Rate in Immuno-Oncology Business (2019-2024)
Figure 53. Dendreon Pharmaceuticals Revenue Growth Rate in Immuno-Oncology Business (2019-2024)
Figure 54. Novartis Revenue Growth Rate in Immuno-Oncology Business (2019-2024)
Figure 55. Gilead Sciences Inc. Revenue Growth Rate in Immuno-Oncology Business (2019-2024)
Figure 56. Merck KGaA Revenue Growth Rate in Immuno-Oncology Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
